Dolby Laboratories
Price chart
Anonymous reader poll. Unscientific, not investment advice.
✦ StockVane Quant Insights how this is computed
- Below its 200-day average or in the bottom third on momentum — the strategy is out of it.
- Signal has read SELL for 3 days.
- Recent price momentum is -13.7% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has risen to 6.4% of float.
- Analyst tilt is Buy.
- Price is below its 20-day average and below its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 2848 U.S. stocks StockVane covers.
Last computed: 2026-11-22 08:27 UTC
Data coverage: 6 of 6 factors. Missing data is not a zero score.
Valuation C+
How expensive the stock is versus earnings, sales and its own 5-year history.
| P/E (TTM) | 20.5x | Better than 41% |
| Forward P/E | 21.0x | Better than 34% |
| Price / Sales | 4.4x | Better than 26% |
| P/E vs own 5-yr range | 25th pctl | Better than 81% |
Growth B
How fast revenue, profit and free cash flow are compounding.
| Revenue CAGR (3Y) | 2.5% | Better than 36% |
| Net income CAGR (3Y) | 11.5% | Better than 62% |
| Free cash flow CAGR (3Y) | 18.4% | Better than 62% |
Profitability A-
How much profit the business keeps from each dollar of sales and capital.
| Gross margin | 88.1% | Better than 95% |
| Operating margin | 20.8% | Better than 78% |
| Net margin | 18.9% | Better than 78% |
| Return on equity | 10.0% | Better than 52% |
| Return on invested capital | 9.8% | Better than 68% |
Momentum C+
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | -15.2% | Better than 39% |
| 6-month return | 1.7% | Better than 59% |
| 12-month return (ex latest month) | -4.7% | Better than 28% |
| Distance below 52-week high | 19.9% | Better than 60% |
Financial Health A+
Balance-sheet strength: leverage, liquidity and interest coverage.
| Current ratio | 3.2x | Better than 75% |
| Debt to assets | 1.2% | Better than 91% |
| Interest coverage | 547.4x | Better than 97% |
| Free cash flow / net income | 168.7% | Better than 71% |
Analyst View A-
What the Street thinks: share of Buy ratings and upside to the average target.
| Analysts rating Buy | 100.0% | Better than 77% |
| Upside to average target | 58.1% | Better than 71% |
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.
Performance
Key statistics
Price & volume
- Prev close
- 54.77
- Open
- 54.75
- Day range
- 54.39 - 58.10
- Avg price
- 55.81
- Volume
- 1.35M
- Turnover
- 75.12M
- Turnover ratei
- 2.33%
- Volume ratioi
- 0.52
- Amplitudei
- 6.77%
- 52-week rangei
- 47.98 - 69.11
Valuation
- P/Ei
- 20.49
- P/E (TTM)i
- 20.49
- P/Bi
- 1.97
- EPSi
- 2.70
- Book value / shi
- 28.08
- Net profit
- 250.35M
- Net assets
- 2.60B
Share structure
- Market cap
- 5.13B
- Float capi
- 3.20B
- Shares out
- 92.72M
- Float sharesi
- 57.82M
Dividend & listing
- Div yield (TTM)i
- 2.60%
- Dividend (TTM)
- 1.44
- Listing date
- 1970-01-01
19.9% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-10.53M net over the window
Short interest
- Shares short
- 6.01M
- % of floati
- 6.41%
- Days to coveri
- 10.01
- As of
- 2026-10-30
Frequently asked questions
What is the current stock price of Dolby Laboratories (DLB)?
Dolby Laboratories last traded at 55.33. This page shows a periodic quote snapshot. Check the displayed quote time.
What is Dolby Laboratories's market cap?
About 5.13B.
What is the P/E ratio of Dolby Laboratories?
The trailing twelve-month P/E is 20.49, below its own 5-year average of 32.90 — toward the bottom of its historical range (24.96% percentile). See the Valuation tab for the full history.
Does Dolby Laboratories pay a dividend?
Yes. The trailing dividend yield is 2.60%. The 2025 payout was up 9.8% from 2024. See the Dividends tab for the full payment history.
Is Dolby Laboratories a buy according to analysts?
The consensus of 3 analysts is a Buy rating, with an average 12-month price target of 87.50, which implies 58.1% upside from the current price. This is not investment advice.
What is Dolby Laboratories's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Dolby Laboratories a D (Sell). Below its 200-day average or in the bottom third on momentum — the strategy is out of it. Not investment advice.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Dolby Laboratories discussion 0 comments